Factors Associated with Hemoglobin A1c among Patient Aged 40 years over with Diabetes Mellitus: 2012 Korea Health and Nutrition Examination Survey.
10.7739/jkafn.2015.22.4.433
- Author:
Eun Joo JI
1
Author Information
1. Department of Nursing, College of Medicine, Catholic Kwandong University, Korea. 93eunjoo@hanmail.net
- Publication Type:Original Article
- Keywords:
Diabetes mellitus;
Vitamin D;
Hemoglobin A1c;
Hypertriglyceridemia
- MeSH:
Blood Glucose;
Cross-Sectional Studies;
Diabetes Mellitus*;
Humans;
Hypertriglyceridemia;
Korea*;
Logistic Models;
Vitamin D
- From:Journal of Korean Academy of Fundamental Nursing
2015;22(4):433-441
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSES: This study was done to identify factors associated with uncontrolled hemoglobin A1c among patient with diabetes mellitus. METHOD: The sample was 412 Koreans with diagnosed diabetes aged 40 years or older who participated in the Fifth Korea Health and Nutrition Examination survey, which was a nationwide, cross-sectional survey. Data was analyzed using logistic regression. Uncontrolled hemoglobin A1c rate was 55%. RESULTS: There was a difference between controlled and uncontrolled group in hemoglobin A1c as follows: duration of diabetes, BMI(Body Mass Index), hypertriglyceridemia, vitamin D, sleep duration. After adjusting for confounding factor, longer duration of diabetes (>7 years vs. < or =7)(Adjusted OR=2.277, 95% CI [1.277-4.060]), presence of hypertriglyceridemia (Adjusted OR=4.019, 95% CI [1.871-8.634]), lower vitamin D level (<20ng/mL vs. > or =20)(Adjusted OR=2.487, 95% CI[1.411-4.381]), longer sleep duration (6-8 hours vs >8 hours)(Adjusted OR=6.831, 95% CI [1.877-24.855]) were significantly associated with increased odds of uncontrolled hemoglobin A1c. CONCLUSIONS: Results show that duration of diabetes, hypertriglyceridemia, vitamin D and sleep duration are significantly related to hemoglobin A1c. Therefore, considering these factors it would be helpful to develop strategies to improve blood glucose control in patients with diabetes.
